# A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

> **NCT03808857** · PHASE2 · UNKNOWN · sponsor: **Genor Biopharma Co., Ltd.** · enrollment: 80 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** GB226

## Key facts

- **NCT ID:** NCT03808857
- **Lead sponsor:** Genor Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-23
- **Primary completion:** 2021-12
- **Final completion:** 2022-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03808857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03808857, "A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03808857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*